INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 21, 2017 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 176,223 | -- | 331,629 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 591,348 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 500,000 |
| Feb 10, 2017 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 5,676 |
| Dec 20, 2016 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Bona fide gift | 1,105 | -- | 66,871 |
| Dec 20, 2016 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Bona fide gift | 1,071 | -- | 65,800 |
| Dec 20, 2016 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Bona fide gift | 670 | -- | 65,130 |
| Dec 20, 2016 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Bona fide gift | 536 | -- | 64,594 |
| Dec 20, 2016 |
Director, President & CSO
|
Director, President & CSO | Form 5 | Bona fide gift | 536 | -- | 64,058 |
| Dec 19, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,676 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.